CCL22 and inflammatory skin disease: In the context of inflammatory skin diseases, CCL17/TARC and CCL22/MDC production is increased epidermal keratinocytes upon stimulation with TNF-α/IFN-γ, resulting infiltration of immune cells into the lesion area [5].